Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study
British Journal of Dermatology, 04/02/2012
Viguier M et al. – Biologics show overall good short–term efficacy, but treatment switch due to lack of efficacy or side effects is frequently observed on a longer term, with one third of patients still receiving the drug after one year. The most significant safety concern consists of severe infections.
